Evidence map›Paper›PMID 40902003›Full record

ArticleNucleic acids research2025

hnRNPL-CstF64 complex: coordinating CSR and LSR in IgH locus recombination dynamics through eRNA and NHEJ regulation.

Farazul Haque, Mikiyo Nakata, Hidetaka Kosako, Tasuku Honjo, Nasim A Begum

Abstract read
In one paragraph

Article in Nucleic acids research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Farazul HaqueDepartment of Immunology and Genomic Medicine, Centre for Cancer Immunotherapy and Immunobiology, Kyoto University Graduate School of Medicine, Kyoto 606-8501, Japan.
Mikiyo NakataDepartment of Immunology and Genomic Medicine, Centre for Cancer Immunotherapy and Immunobiology, Kyoto University Graduate School of Medicine, Kyoto 606-8501, Japan.
Hidetaka KosakoDivision of Cell Signaling, Institute of Advanced Medical Sciences, Tokushima University, Tokushima 770-8503, Japan.
Tasuku HonjoDepartment of Immunology and Genomic Medicine, Centre for Cancer Immunotherapy and Immunobiology, Kyoto University Graduate School of Medicine, Kyoto 606-8501, Japan.ORCID 0000-0003-2300-3928
Nasim A BegumDepartment of Immunology and Genomic Medicine, Centre for Cancer Immunotherapy and Immunobiology, Kyoto University Graduate School of Medicine, Kyoto 606-8501, Japan.ORCID 0000-0001-7177-188X

Funding

Japan Society for the Promotion of Science 21K06015Japan Society for the Promotion of Science 22H00449Japan Society for the Promotion of Science 24K09325Japan Society for the Promotion of Science 25H01028
6 · The paper itself

Abstract

Class switch recombination (CSR) and locus suicide recombination (LSR) are critical processes involved in the immune system's ability to diversify antibody responses. Both are initiated by activation-induced cytidine deaminase, which induces DNA double-strand breaks (DSBs) at specific regions within the immunoglobulin heavy chain (IgH) locus. In CSR, DSBs occur at the switch (S) regions, allowing B cells to replace the IgM heavy chain constant region (CH) with other isotypes, thereby enhancing immune adaptability. This process is regulated by both cis and trans mechanisms, including the IgH super-enhancer 3' regulatory region (3'RR) and the production of enhancer RNAs (eRNAs). A recent study highlighted the role of MED12 in CSR through enhancer activation and the transcription of eRNA. Now, we show that heterogeneous ribonucleoprotein L (hnRNPL) acts as an additional regulator of CSR and LSR by forming an eRNA-associated complex with CstF64, a polyadenylation factor. This complex facilitates RNA polymerase II elongation and eRNA transcription at the 3'RR. Moreover, the hnRNPL/CstF64 complex promotes NHEJ-mediated DNA repair at both S and 3'RR regions, facilitating 53BP1 and Ku80 recruitment, thereby impacting the efficiency of CSR and LSR. This discovery highlights the intricate, multimodal regulation of these processes, linking eRNA transcription to DNA repair in the process of antibody diversification.

Indexed as

DNA End-Joining RepairImmunoglobulin Class SwitchingImmunoglobulin Heavy ChainsRNA-Binding ProteinsAnimalsB-LymphocytesDNA Breaks, Double-StrandedEnhancer Elements, GeneticHumansMiceImmunoglobulin Heavy ChainsRNA-Binding Proteins

Identifiers

PMID40902003
PMCPMC12407099

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.